[Stroke and depression]

Area of Science:

• Neurology
• Psychiatry
• Clinical Medicine

Background:

• Depression is a common complication after stroke, affecting about one in three survivors.
• Post-stroke depression significantly worsens neurological outcomes, physical function, quality of life, and increases mortality risk.
• It also reduces the effectiveness of rehabilitation and therapeutic interventions.

Purpose of the Study:

• To review the impact of depression on stroke recovery.
• To evaluate the efficacy of antidepressants in managing post-stroke depression.
• To identify areas for future research in treating depression in stroke patients.

Main Methods:

• Literature review of studies on post-stroke depression and antidepressant treatment.
• Analysis of the effects of depression on neurological recovery and patient outcomes.
• Evaluation of different classes of antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and tricyclic drugs.

Main Results:

• Antidepressants are effective in alleviating depressive symptoms, mitigating neurological deficits, and improving cognitive function in post-stroke patients.
• Treatment with antidepressants enhances the effectiveness of rehabilitation, improves overall patient condition, and reduces the risk of recurrent stroke and death.
• Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment, with evidence supporting other modern antidepressants and tricyclic drugs.

Conclusions:

• Antidepressant therapy is crucial for managing depression after stroke, leading to improved functional recovery and survival.
• Further research is needed on the tolerability in elderly patients, optimal drug selection, and therapy duration.
• Addressing post-stroke depression is essential for optimizing patient outcomes and reducing healthcare burden.